3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Stomach Neoplasms
1
Neutropenia
1
Neoplasms
1
Mucositis
1
Leukemia, Myeloid, Acute
1
Infections
1
Hyperphagia
1
Esophageal Neoplasms
1
Colitis
1
Adenocarcinoma Of Esophagus
1
Interventions
pegfilgrastim
13
Filgrastim
13
Cytarabine
5
Cyclophosphamide
5
pegylated granulocyte colony-stimulating factor
4
Etoposide
4
Methotrexate
3
Doxorubicin
3
Docetaxel
3
trifluridine tipiracil drug combination
2
Vincristine
2
Daunorubicin
2
Cisplatin
2
Amifostine
2
trilaciclib
1
niraparib
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
fish oil triglycerides
1
etoposide phosphate
1
eravacycline
1
eflapegrastim
1
angiotensin I (1-7)
1
Voriconazole
1
Vegetables
1
Topotecan
1
Thioguanine
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neutropenia
×
fish oil triglycerides
×
Clear all
NCT00533078
2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2
Completed
14 enrolled